Ignite Creation Date:
2024-05-05 @ 6:35 PM
Last Modification Date:
2024-10-26 @ 9:34 AM
Study NCT ID:
NCT00506415
Status:
COMPLETED
Last Update Posted:
2012-09-19
First Post:
2007-07-20
Brief Title:
Comparative Efficacy Safety and Tolerability of Rivastigmine 10 and 15 cm2 Patch in Patients With Alzheimers Disease AD Showing Cognitive Decline
Sponsor:
Novartis Pharmaceuticals
Organization:
Novartis
Key Dates - Follows AllAPIJSON File Order
Start Date:
2007-06
Start Date Type:
None
Primary Completion Date:
2011-05
Primary Completion Date Type:
ACTUAL
Completion Date:
2011-05
Completion Date Type:
ACTUAL
First Submit Date:
2007-07-20
First Submit QC Date:
July 20 2007
Study First Post Date:
2007-07-25
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
2012-09-19
Results First Post Date Type:
ESTIMATED
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2012-09-17
Last Update Post Date:
2012-09-19
Last Update Post Date Type:
ESTIMATED